Stockreport

Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights

Clene Inc.  (CLNN) 
PDF In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8® data submitted; Clene expects formal written meeting minutes ea [Read more]